CAS 1584713-87-0

BMS-983970

Kontrolliertes Produkt

CAS: 1584713-87-0

BMS-983970 is a small molecule that inhibits the transcription factor NF-κB. It has shown to have an anti-tumor activity in clinical studies, and is currently being investigated for use in metastatic cancer. BMS-983970 also enhances the effect of cytotoxic agents on tumor cells, which may be due to its ability to inhibit the process of apoptosis. BMS-983970 has been shown to be active against lymphoblastic leukemia cell lines, colorectal carcinoma cell lines, and lung cancer cell lines. This drug is also being researched for its potential use in acute lymphoblastic leukemia treatment.

Formel: C₂₆H₂₆F₄N₄O₃

Reinheit: Min. 95%

Molekulargewicht: 518.5 g/mol

Ref: 3D-JNC71387

BMS-983970

CAS: 1584713-87-0

BMS-983970 is an oral inhibitor of pan-Notch, and for the treatment of multiplecancers.

Formel: C₂₆H₂₆F₄N₄O₃

Farbe und Form: Solid

Molekulargewicht: 518.5

Ref: TM-T14683